IOVANCE BIOTHERAPEUTICS, INC. Letters of Credit Outstanding, Amount
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Letters of Credit Outstanding, Amount of $60.00 million as of 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Notes › Other Liabilities
us-gaap:LettersOfCreditOutstandingAmount · last filed 2023-11-07
- 2023-09-30: Letters of Credit Outstanding, Amount $60.00M.
- 2023-06-30: Letters of Credit Outstanding, Amount $60.00M.
- 2021-12-31: Letters of Credit Outstanding, Amount $1.00M.
- 2021-09-30: Letters of Credit Outstanding, Amount $1.00M.
| Period end | Letters of Credit Outstanding, Amount |
|---|---|
| 2023-09-30 | $60.00M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $60.00M 10-Q · filed 2023-08-08 |
| 2021-12-31 | $1.00M 10-K · filed 2022-02-24 |
| 2021-09-30 | $1.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.00M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.00M 10-K · filed 2021-02-25 |
| 2020-09-30 | $1.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.00M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $1.00M 10-K · filed 2020-02-25 |
| 2019-09-30 | $1.00M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $1.00M 10-Q · filed 2019-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |